GLP-1 Medication Cost & Insurance Coverage

The list prices for GLP-1 medications can be significant, often exceeding $1,000 per month without insurance. However, the amount you actually pay depends on many factors including your insurance coverage, the specific medication, and available savings programs.

Commercial insurance coverage for GLP-1 medications varies significantly by plan and by the indication for which the medication is prescribed.

• Type 2 Diabetes: Many commercial plans cover GLP-1 medications when prescribed for type 2 diabetes, though they may require prior authorization or step therapy (trying other medications first).
• Weight Management: Coverage for weight management indications is less consistent. Some plans explicitly exclude weight loss medications, while others have begun covering FDA-approved options like Wegovy and Zepbound.
• Prior Authorization: Most plans require prior authorization, meaning your provider must demonstrate medical necessity before the medication is approved.

Medicare Part D coverage for GLP-1 medications has historically been limited:

• Diabetes Indication: Medicare Part D plans may cover GLP-1 medications when prescribed for type 2 diabetes, though formulary placement and cost-sharing vary.
• Weight Management Exclusion: By law, Medicare Part D has not covered medications prescribed solely for weight loss. However, policy discussions about expanding coverage are ongoing.
• Recent Changes: The Inflation Reduction Act has begun to impact Medicare drug costs, and future policy changes may affect GLP-1 coverage.

Medicaid coverage varies by state. Some state Medicaid programs cover GLP-1 medications for diabetes, while coverage for weight management is less common. Contact your state Medicaid office or managed care plan for specific coverage information.

Pharmaceutical manufacturers offer savings programs that can significantly reduce out-of-pocket costs for eligible patients. These programs typically have restrictions and are not available to patients on government insurance.

Note: Savings program terms change frequently. Visit manufacturer websites for current eligibility requirements and savings amounts.

Due to high costs and supply shortages, some patients have sought compounded versions of semaglutide and tirzepatide. Important considerations:

• Legality: Under FDA regulations, compounding pharmacies can prepare copies of approved drugs only when those drugs are on the official shortage list. Once a shortage ends, compounded versions may no longer be legally available.
• Safety Concerns: Compounded medications are not FDA-approved and may not meet the same quality and sterility standards as brand-name products.
• Dosing Variations: The concentration and formulation of compounded products may differ from FDA-approved versions.

Important: Discuss any interest in compounded medications with your healthcare provider. The FDA has issued warnings about potential risks associated with non-FDA-approved versions of these medications.

If you're facing high costs for GLP-1 medications, consider these strategies:

• Ask your provider about manufacturer savings programs before filling your prescription
• Check if your insurance requires prior authorization and help your provider complete it
• Compare prices at different pharmacies — costs can vary significantly
• Consider mail-order pharmacies which may offer better pricing
• Ask about patient assistance programs if you have limited income
• Check if your employer offers any weight management benefits
• Review your insurance formulary to understand which medications are covered
• Appeal insurance denials — many initial denials are overturned on appeal

For information about obtaining a prescription, see our guide on how to get GLP-1 medications.